| Jun 7 |
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
| May 29 |
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
|
| May 28 |
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
|
| May 23 |
Jaguar Health extends losses as reverse stock split takes effect
|
| May 23 |
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
|
| May 20 |
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
|
| May 20 |
Why Jaguar Health Stock Is Tanking
|
| May 20 |
Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
|
| May 17 |
Jaguar Health announces 1-for-60 reverse stock split
|
| May 17 |
Jaguar Health, Inc. Announces Reverse Stock Split
|
